课题基金 / 基金详情

CD1d-restricted NKT cells in microbial infection

CD1d-restricted NKT cells in microbial infection
微生物感染中 CD1d 限制性 NKT 细胞
批准号:
8010196
负责人:
Manfred Brigl
金额:
$13.64万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-15 至 2013-01-31

项目摘要

项目成果

Manfred Brigl的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本提案描述了一个为期5年的培训计划,用于发展临床病理学的学术生涯。候选人正在波士顿哈佛医学院完成临床实验室医学的住院医师培训,现在打算扩大他在基础免疫生物学和传染病免疫学研究方面的科学背景和技能。该计划将在赞助商的实验室中提供CD1抗原呈递和T细胞功能领域的指导研究,Michael Brenner博士是波士顿Brigham妇女医院的流变学,免疫学和过敏学部门的负责人,他是CD1生物学领域的公认领导者。Brenner博士在成功培训临床科学家方面有着出色的记录。为了成功培训和完成该提案的B细胞生物学方面,B细胞生物学领域公认的专家Shiv Pillai博士将担任共同导师。除了开发一个独立的项目领域外,该计划与课程,讲座,研讨会和职业指导的互补将促进候选人发展成为一名独立的学术调查员。拟议的研究项目将研究自然杀伤T(NKT)细胞的功能,NKT细胞是一种识别CD1d呈递的脂质和糖脂抗原的T细胞亚群。NKT细胞与宿主防御微生物感染密切相关,然而,关于微生物感染期间NKT细胞活化的机制以及NKT细胞与免疫系统的其他细胞在产生成功的保护性免疫应答期间的相互作用知之甚少。我们建议检查NKT细胞在感染有包膜的病原体肺炎链球菌过程中的作用和功能。为了研究感染过程中NKT细胞活化的机制,我们将确定TLR介导的信号传导、细胞因子信号传导和自身抗原识别在NKT细胞对S.肺炎(Aim 1)。此外,我们将从S.肺炎杆菌中,并确定这些化合物是否可以被NKT细胞识别为同源的CD 1d呈递抗原(Aim 2)。接下来,我们将研究NKT细胞在S.肺炎病毒感染,特别是荚膜多糖抗原(Aim 3)。这些研究旨在解决有关NKT细胞在微生物免疫中的功能的基本未回答的问题。这对宿主防御感染和其他疾病具有重要意义。链球菌感染肺炎是美国疾病和死亡的主要原因。拟议的研究对于了解这种病原体的免疫力非常重要,并可能导致免疫保护和疫苗开发的新策略。
英文摘要
DESCRIPTION (provided by applicant): This proposal describes a 5-year training program for the development of an academic career in Clinical Pathology. The candidate is completing residency training in clinical laboratory medicine at Harvard Medical School, Boston, and now proposes to expand his scientific background and skills in research of basic immunobiology and immunology of infectious diseases. The program will provide mentored research in the area of CD1 antigen presentation and T cell function in the laboratory of the sponsor, Dr. Michael Brenner, Chief of the Division of Rheumatology, Immunology and Allergy at Brigham and Women's Hospital, Boston, who is a recognized leader in the field of CD1 biology. Dr. Brenner has an outstanding record of successfully training clinician scientists. In order to allow successful training in and completion of the B cell biology aspect of the proposal, Dr. Shiv Pillai, a recognized expert in the field of B cell biology, will serve as co-mentor. In addition to the development of an independent project area, the complementation of the program with coursework, lectures, seminars and career mentoring will promote the candidate's development into an independent academic investigator. The proposed research project will investigate the function of Natural Killer T (NKT) cells, a specialized subset of T cells that recognizes CD1d-presented lipid and glycolipid antigens. NKT cells have been strongly implicated in host defense to microbial infection, however, little is known about both the mechanism of NKT cell activation during microbial infection and the interaction of NKT cells with other cells of the immune system during the generation of a successful protective immune response. We propose to examine the role and function of NKT cells during infection with the encapsulated pathogen Streptococcus pneumoniae. To investigate the mechanism of NKT cell activation during this infection, we will determine the role of TLR-mediated signaling, cytokine signaling and self-antigen recognition for NKT cell responses to S. pneumoniae (Aim 1). In addition, we will isolate lipids and lipidated polysaccharides from S. pneumoniae bacteria and determine whether these compounds can be recognized by NKT cells as cognate CD1d- presented antigens (Aim 2). Next, we will examine the role of NKT cells in generating a protective antibody response during S. pneumoniae infection, in particular to capsular polysaccharide antigens (Aim 3). These studies seek to address fundamental unanswered questions regarding the function of NKT cells in microbial immunity. This has significance for host defense to infection and other diseases. Infection with S. pneumoniae is a leading cause of illness and death in the United States. The proposed studies are important for understanding immunity to this pathogen and could lead to new strategies for immune protection and vaccine development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MR1 and MAIT Cell Function in Intestinal Infection
  • 批准号:
    9302658
  • 项目类别:
  • 资助金额:
    $62.17万
  • 财政年份:
    2016
  • 负责人:
    Manfred Brigl
  • 依托单位:
Role of type II NKT cells during M. tuberculosis infection
  • 批准号:
    8582986
  • 项目类别:
  • 资助金额:
    $21.54万
  • 财政年份:
    2013
  • 负责人:
    Manfred Brigl
  • 依托单位:
Role of type II NKT cells during M. tuberculosis infection
  • 批准号:
    8665379
  • 项目类别:
  • 资助金额:
    $24.51万
  • 财政年份:
    2013
  • 负责人:
    Manfred Brigl
  • 依托单位:
CD1d-restricted NKT cells in microbial infection
  • 批准号:
    8112316
  • 项目类别:
  • 资助金额:
    $5.0万
  • 财政年份:
    2010
  • 负责人:
    Manfred Brigl
  • 依托单位:
海外基金